Clinical Trials Logo

Epilepsies, Myoclonic clinical trials

View clinical trials related to Epilepsies, Myoclonic.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02239276 No longer available - Dravet Syndrome Clinical Trials

Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access use of Stiripentol in Dravet Syndrome or epileptic encephalopathies associated with sodium channel mutations who have failed other drugs in an effort to give them the best chance at seizure control and quality of life. As a treatment protocol and not a research study, children will only be monitored on a clinical basis for seizure improvement and side effects predominantly by parent and caregiver report.

NCT ID: NCT01835314 No longer available - Dravet Syndrome Clinical Trials

Compassionate Use of Stiripentol in Dravet Syndrome

Start date: n/a
Phase:
Study type: Expanded Access

Compassionate use of Stiripentol in Dravet Syndrome. This is a treatment protocol, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.

NCT ID: NCT01533506 No longer available - Dravet Syndrome Clinical Trials

Stiripentol in Dravet Syndrome

Start date: February 2012
Phase: Phase 4
Study type: Expanded Access

The patient has failed all other available agents and has intractable epilepsy due to Dravet Syndrome. Stiripentol is highly efficacious in Dravet Syndrome. The overall goals of therapy with Stiripentol are primarily to significantly reduce the frequency and severity of seizures.